TGF-β/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells

TGF-β/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells

The TGF-β and Hippo pathways are critical for liver size control, regeneration, and cancer progression. The transcriptional cofactor TAZ, also named WWTR1, is a downstream effector of Hippo pathway and plays a key role in the maintenance of liver physiological functions. However, the up-regulation o...

Full description

Bibliographic Details
Main Authors:	Diana G. Ríos-López, Angeles C. Tecalco-Cruz, David Martínez-Pastor, Marcela Sosa-Garrocho, Gustavo Tapia-Urzúa, Yuli Aranda-López, Bibiana Ortega-Domínguez, Félix Recillas-Targa, Genaro Vázquez-Victorio, Marina Macías-Silva
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Heliyon
Subjects:	TGF-β cytokine Hippo-pathway TAZ cofactor HepG2 cells Liver cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023087273

Similar Items

Regulation of TAZ in cancer
by: Xin Zhou, et al.
Published: (2016-07-01)

YAP/TAZ Activation as a Target for Treating Metastatic Cancer
by: Janine S. A. Warren, et al.
Published: (2018-04-01)

Inhibition of TAZ impairs the migration ability of melanoma cells
by: Zhang Hao, et al.
Published: (2023-06-01)

TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway
by: Kaihua Ji, et al.
Published: (2018-08-01)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
by: Gandhi T. K. Boopathy, et al.
Published: (2019-04-01)

TAZ facilitates breast tumor growth by promoting an immune‐suppressive tumor microenvironment
by: Anat Gershoni, et al.
Published: (2023-12-01)

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing
by: Chao Tang, et al.
Published: (2023-02-01)

Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ–CAMTA1 Fusion Driven Sarcoma
by: Caleb N. Seavey, et al.
Published: (2022-06-01)

Roles of Hippo–YAP/TAZ signalling in intervertebral disc degeneration
by: Shi Zheng-wei, et al.
Published: (2023-03-01)

YAP/TAZ: a promising target for squamous cell carcinoma treatment
by: Dong X, et al.
Published: (2019-07-01)

Yap/Taz inhibit goblet cell fate to maintain lung epithelial homeostasis
by: Julia Hicks-Berthet, et al.
Published: (2021-07-01)

Role of YAP/TAZ in Cell Lineage Fate Determination and Related Signaling Pathways
by: Boon C. Heng, et al.
Published: (2020-07-01)

Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
by: Aviral Kumar, et al.
Published: (2024-05-01)

Mechanical Properties of Glioblastoma: Perspectives for YAP/TAZ Signaling Pathway and Beyond
by: Bruno Pontes, et al.
Published: (2023-06-01)

Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
by: Du Jiamin, et al.
Published: (2022-09-01)

Distinctive Roles of YAP and TAZ in Human Endothelial Progenitor Cells Growth and Functions
by: Phatchanat Klaihmon, et al.
Published: (2022-01-01)

Mechanisms of YAP/TAZ transcriptional control
by: Giusy Battilana, et al.
Published: (2021-10-01)

New insights into the ambivalent role of YAP/TAZ in human cancers
by: Juan Luo, et al.
Published: (2023-05-01)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
by: Oleg Dobrokhotov, et al.
Published: (2018-08-01)

TGF‐β/Smads signaling pathway, Hippo‐YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases
by: Hui Liu, et al.
Published: (2023-11-01)

YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation
by: Nattaya Damkham, et al.
Published: (2022-09-01)

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
by: Ruize Gao, et al.
Published: (2021-12-01)

New insights into YAP/TAZ nucleo‐cytoplasmic shuttling: new cancer therapeutic opportunities?
by: Michal Shreberk‐Shaked, et al.
Published: (2019-06-01)

Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
by: Ajaybabu V. Pobbati, et al.
Published: (2020-12-01)

Hippo-YAP/TAZ pathway regulation: the crucial roles of lncRNAs in cancer
by: Wonyi Jang, et al.
Published: (2023-12-01)

Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer
by: Sahar Sarmasti Emami, et al.
Published: (2024-04-01)

The Hippo Signaling Core Components YAP and TAZ as New Prognostic Factors in Lung Cancer
by: Yu Jiang, et al.
Published: (2022-03-01)

Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm
by: Linling Jin, et al.
Published: (2020-06-01)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
by: Reza Bayat Mokhtari, et al.
Published: (2023-07-01)

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
by: Antonio Cigliano, et al.
Published: (2022-06-01)

Pharmacological activation of TAZ enhances osteogenic differentiation and bone formation of adipose-derived stem cells
by: Yumin Zhu, et al.
Published: (2018-03-01)

Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation
by: Juan Luo, et al.
Published: (2022-01-01)

Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
by: Farhoud Faraji, et al.
Published: (2022-04-01)

Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma
by: John M. Lamar, et al.
Published: (2018-07-01)

Hippo-YAP/TAZ signaling in osteogenesis and macrophage polarization: Therapeutic implications in bone defect repair
by: Haochen Wang, et al.
Published: (2023-11-01)

Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach
by: He Shen, et al.
Published: (2021-06-01)

Clinical and biological implications of Hippo pathway dysregulation in sarcomas
by: Kyriazoglou Anastasios, et al.
Published: (2019-07-01)

Analysis of the role of the Hippo pathway in cancer
by: Yanyan Han
Published: (2019-04-01)

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
by: Taha Azad, et al.
Published: (2019-05-01)

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
by: Elisa Melucci, et al.
Published: (2018-02-01)